Skip to main content
Clinical Trials/NCT05488769
NCT05488769
Terminated
Not Applicable

Visual Outcomes and Patient Satisfaction After Bilateral Implantation of Non-diffractive EDOF IOL Made of a New Hydrophobic Acrylic Material

Thomas Nagy1 site in 1 country6 target enrollmentAugust 25, 2022
ConditionsCataract

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cataract
Sponsor
Thomas Nagy
Enrollment
6
Locations
1
Primary Endpoint
Binocular distance-corrected visual acuity at distance (6m)
Status
Terminated
Last Updated
3 years ago

Overview

Brief Summary

The objective is to measure the range of vision and patient reported visual disturbances after bilateral implantation for this unique non-diffractive extended depth of focus (EDOF) intraocular lens (IOL) made from the Clareon material.

Detailed Description

This study is a single-arm unmasked clinical evaluation study of binocular distance-corrected distance (6m) and intermediate (66cm) visual acuity after successful bilateral cataract surgery. Subjects will be assessed pre-operatively, operatively and at 1 day, 1 month and 3 months post-operatively. Clinical evaluations will include administration of a visual disturbance questionnaire (QUVID), and a satisfaction questionnaire (IOLSAT), as well as measurement of bilateral visual acuity and manifest refraction.

Registry
clinicaltrials.gov
Start Date
August 25, 2022
End Date
November 29, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor Investigator
Principal Investigator

Thomas Nagy

Principal Investigator

Vision North Eye Centre

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Binocular distance-corrected visual acuity at distance (6m)

Time Frame: 3 months postoperative

Binocular distance-corrected visual acuity at intermediate (66cm)

Time Frame: 3 months postoperative

Secondary Outcomes

  • Percentage of eyes with absolute prediction error less than or equal to 0.50D(3 months postoperative)
  • Percentage of eyes with refractive astigmatism less than or equal to 0.50 D(3 months postoperative)

Study Sites (1)

Loading locations...

Similar Trials